Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond ...

Moderna (MRNA) was in focus Thursday morning after the vaccine maker announced plans to expand its cost efficiency and ...

A new study about the safety of the COVID-19 MRNA vaccines directly challenges public health officials’ claims and raises ...

It plays a vital role in mRNA vaccines, such as those used for COVID-19, and is also a promising tool for treating diseases like cancer and genetic disorders. When foreign mRNA, such as those in ...

Lipid nanoparticle (LNP) mRNA vaccines emerged during the COVID-19 pandemic to form an ... The Enzyme-Linked ImmunoSpot (ELISpot) platform assesses cytokine production and is the most commonly ...

The surprise delay is casting new uncertainty on the fate of another vaccine awaiting FDA action: Moderna’s next-generation Covid-19 shot, called mRNA-1283, which is set for a decision by May 31.

01. Confusion over the Food and Drug Administration’s delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend when the agency’s commissioner, Marty Makary ...

"He has advised me not to take any mRNA vaccines," she said. She, like many people with long COVID, relies on COVID boosters to avoid reinfections with the virus, which can cause their symptoms to ...

During the COVID-19 pandemic ... similar to traditional vaccines, including messenger RNA (mRNA) vaccines. This dual action can rapidly slow viral replication and limit its spread within the ...

mRNA vaccines made by Pfizer and Moderna, have earned full FDA approval for certain age groups. Because the coronavirus continually mutates, manufacturers follow instructions from FDA to make one ...